XML 86 R54.htm IDEA: XBRL DOCUMENT v3.25.1
Share-based compensation (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of activity of restricted share units
The following table summarizes the activity of restricted share units during fiscal years 2024, 2023 and 2022: 
 UnitsWeighted-average grant-date fair value
Outstanding at December 31, 2021186,796 8.70 
Partial vesting of 2017 grant(51,613)9.20 
Partial vesting of 2018 grant(64,895)8.50 
Forfeitures(8,522)8.62 
Outstanding at December 31, 202261,766 8.50 
Partial vesting of 2018 grant(60,623)8.50 
Forfeitures(1,143)8.50 
Outstanding at December 31, 2023— — 
Outstanding at December 31, 2024— — 
Exercisable at December 31, 2024— — 
Summary of phantom RSU award activity
The following table provides information about the awards granted by the Company and pending of vesting as of December 31, 2024:
GrantUnitsVesting period
2022795,013May 2025
2023733,972May 2026
202428,800April 2025
620,529May 2027
The following table summarizes the activity under the plan as of December 31, 2024:
UnitsSettlement
Outstanding at December 31, 20212,040,488 $— 
Grant 2022907,536 — 
Partial vesting of 2019 grant(63,257)431 
Vesting of 2021 grant(44,093)320 
Forfeitures(128,919)— 
Outstanding at December 31, 20222,711,755 — 
Grant 2023769,375 — 
Partial vesting of 2019 grant(59,616)512 
Vesting of 2022 grant(41,055)326 
Forfeitures(180,272)— 
Outstanding at December 31, 20233,200,187 — 
Grant 2024651,575 
Vesting of 2019 grant(943,288)10,480 
Vesting of 2021 grant(692,422)7,693 
Vesting of 2023 grant(32,599)351 
Forfeitures(5,139)
Outstanding at December 31, 20242,178,314 — 
The following table provides a summary of the plan as of December 31, 2024:
Total Non-vested (i)
Number of units outstanding
2,178,314 
Current share price7.28 
Total fair value of the plan15,858 
Weighted-average accumulated percentage of service57.63 %
Accrued liability (ii)9,139 
Compensation expense not yet recognized (iii)6,719 

(i)Related to awards that will vest between April 2025 and May 2027.
(ii)Presented within “Accrued payroll and other liabilities” in the Company’s current and non-current liabilities balance sheet.
(iii)Expected to be recognized in a weighted-average period of 1.8 years.